Literature DB >> 19641342

Confined stimulation using dual thalamic deep brain stimulation leads rescues refractory essential tremor: report of three cases.

Hong Yu1, Peter Hedera, John Fang, Thomas L Davis, Peter E Konrad.   

Abstract

BACKGROUND/AIMS: Deep brain stimulation (DBS) of the nucleus ventralis intermedius (VIM) provides a safe and effective therapy for medically refractory essential tremor (ET). However, as many as 9% of VIM DBS patients deteriorate after several years of good tremor control. For these patients, the high voltage needed to adequately control tremor also generates circumferential current spread causing intolerable adverse effects.
METHODS: We report 3 ET patients where adding a second parallel thalamic lead anterior-medially to the original and connecting the 2 adjacent leads to a dual-channel pulse generator (Medtronic Synergy, model No. 7427) successfully recaptured tremor control with fewer adverse effects.
RESULTS: This approach allowed us to direct the stimulation field away from nearby structures responsible for the adverse effects. Such confined stimulation can be achieved by connecting 2 adjacent DBS leads to a common voltage source, providing current flow between leads.
CONCLUSION: This dual lead stimulation method can be used as a reversible rescue therapy in ET patients who require unacceptably high intensity stimulation. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19641342     DOI: 10.1159/000230694

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  12 in total

1.  Improved spatial targeting with directionally segmented deep brain stimulation leads for treating essential tremor.

Authors:  Maureen Keane; Steve Deyo; Aviva Abosch; Jawad A Bajwa; Matthew D Johnson
Journal:  J Neural Eng       Date:  2012-06-25       Impact factor: 5.379

2.  A method for pre-operative single-subject thalamic segmentation based on probabilistic tractography for essential tremor deep brain stimulation.

Authors:  Erik H Middlebrooks; Vanessa M Holanda; Ibrahim S Tuna; Hrishikesh D Deshpande; Markus Bredel; Leonardo Almeida; Harrison C Walker; Barton L Guthrie; Kelly D Foote; Michael S Okun
Journal:  Neuroradiology       Date:  2018-01-06       Impact factor: 2.804

3.  Comparing two deep brain stimulation leads to one in refractory tremor.

Authors:  R Mehanna; A G Machado; S Oravivattanakul; G Genc; S E Cooper
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

Review 4.  Emerging strategies in the management of essential tremor.

Authors:  Peter Hedera
Journal:  Ther Adv Neurol Disord       Date:  2016-11-30       Impact factor: 6.570

Review 5.  Rescue Procedures after Suboptimal Deep Brain Stimulation Outcomes in Common Movement Disorders.

Authors:  Adam M Nagy; Christopher M Tolleson
Journal:  Brain Sci       Date:  2016-10-08

Review 6.  The role of deep brain stimulation in Parkinson's disease: an overview and update on new developments.

Authors:  John Y Fang; Christopher Tolleson
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-07       Impact factor: 2.570

7.  High-voltage VIM Region Deep Brain Stimulation Mimicking Progressive Supranuclear Palsy.

Authors:  Addie Patterson; Michael S Okun; Christopher Hess
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-03-20

8.  [The use of neuromodulation for the treatment of tremor].

Authors:  Damián Bendersky; Pablo Ajler; Claudio Yampolsky
Journal:  Surg Neurol Int       Date:  2014-08-04

9.  Multimodal 7T Imaging of Thalamic Nuclei for Preclinical Deep Brain Stimulation Applications.

Authors:  YiZi Xiao; Laura M Zitella; Yuval Duchin; Benjamin A Teplitzky; Daniel Kastl; Gregor Adriany; Essa Yacoub; Noam Harel; Matthew D Johnson
Journal:  Front Neurosci       Date:  2016-06-10       Impact factor: 4.677

Review 10.  Deep brain stimulation for the treatment of uncommon tremor syndromes.

Authors:  Adolfo Ramirez-Zamora; Michael S Okun
Journal:  Expert Rev Neurother       Date:  2016-06-09       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.